TickerFacts.

Pharma-Bio Serv, Inc. (PBSV): Cash & Equivalents

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2017-10-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2022-10-31, while the company's latest annual report covers the year ended 2025-10-31. Its later filings do not report this line under the concept TickerFacts maps.

$14.46M
As of 2022-10-31
-2.3%
3-year compound annual growth
+4.5%
5-year compound annual growth
$17.47M2010-10-31: $2.32M2011-10-31: $4.32M2012-10-31: $6.54M2013-10-31: $12.05M2014-10-31: $15.09M2015-10-31: $14.89M2016-10-31: $13.77M2017-10-31: $11.59M2018-10-31: $16.03M2019-10-31: $15.49M2020-10-31: $17.14M2021-10-31: $17.47M2022-10-31: $14.46M$14.46M
2010-10-31 Cash & Equivalents (USD) 2022-10-31
Period endedCash & EquivalentsChange YoYSource filing
2022-10-31$14.46M-17.2%2023-01-30, Balance as of period end
2021-10-31$17.47M+1.9%2023-01-30, Balance as of period end
2020-10-31$17.14M+10.6%2022-02-11, Balance as of period end
2019-10-31$15.49M-3.4%2021-02-01, Balance as of period end
2018-10-31$16.03M+38.3%2020-01-29, Balance as of period end
2017-10-31$11.59Mn/c2019-01-29, Balance as of period end
2016-10-31$13.77M-7.5%2018-01-29, Balance as of period end
2015-10-31$14.89M-1.3%2017-01-31, Balance as of period end
2014-10-31$15.09M+25.3%2016-01-29, Balance as of period end
2013-10-31$12.05M+84.2%2015-01-29, Balance as of period end
2012-10-31$6.54M+51.5%2014-01-29, Balance as of period end
2011-10-31$4.32M+86.3%2013-01-29, Balance as of period end
2010-10-31$2.32Mn/a2012-01-31, Balance as of period end